<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7824064\results\search\disease\results.xml">
  <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract The medical burden caused by respiratory manifestations of" exact="influenza" post="virus (IV) outbreak as an infectious respiratory disease is"/>
  <result pre="respiratory manifestations of influenza virus (IV) outbreak as an infectious" exact="respiratory disease" post="is so great that governments in both developed and"/>
  <result pre="to the flavonols class and has shown therapeutic effects against" exact="influenza" post="virus. The focus of this review includes viral pathogenesis"/>
  <result pre="quercetin and its derivatives as a complementary therapy in controlling" exact="influenza" post="and its related symptoms based on the targets. We"/>
  <result pre="for treatment of SARS-COV-2, the cause of new pandemic. flavonols" exact="influenza" post="virus medicinal plants quercetin quercetin derivatives SASRS-COV-2 1. Introduction"/>
  <result pre="about 290,000â€&quot;650,000 people worldwide in one season [5]. Beside deaths," exact="influenza" post="may cause respiratory, diabetic, cardiovascular, renal, and neurological complications"/>
  <result pre="complications as reviewed in [6,7]. Additionally, the estimated cost of" exact="influenza" post="infection in the United States alone amounts to about"/>
  <result pre="date, at least 13 cases of coinfection of Covid-19 and" exact="influenza" post="have been reported in PubMed-listed articles. A larger prevalence"/>
  <result pre="COVID-19 alone [10]. One report suggested a protective effect of" exact="influenza" post="infection against infection with COVID-19 [11]. Coinfection was also"/>
  <result pre="for Emergencies) report was released concerning coinfection of COVID-19 and" exact="influenza" post="in hospitalized patients. About 18% of hospitalized Covid-19 patients"/>
  <result pre="About 18% of hospitalized Covid-19 patients that were tested for" exact="influenza" post="were also carrying influenza virus. Only 3.9% of all"/>
  <result pre="Covid-19 patients that were tested for influenza were also carrying" exact="influenza" post="virus. Only 3.9% of all COVID-19-positive cases were also"/>
  <result pre="also cross-tested for influenza, and only 0.7% of them were" exact="influenza" post="positive [13]. The consequences of coinfections were an increased"/>
  <result pre="treatment. One category of anti-influenza drugs, neuraminidase inhibitors (NAI), inhibits" exact="influenza" post="virus neuraminidase reducing viral shedding within the respiratory tract"/>
  <result pre="domain of the viral M2 protein [16]. Severe cases of" exact="influenza" post="infection are associated with the risk of death, especially"/>
  <result pre="the improved development of conventional antiviral agents, their effectiveness against" exact="influenza" post="viruses is limited [19] and their clinical efficacy is"/>
  <result pre="is also ambiguous [20,21,22]. Moreover, dramatic increases in resistance of" exact="influenza" post="virus against these drugs have been reported [23,24,25,26,27], although"/>
  <result pre="inhibitors has remained at low levels [28]. Severe cases of" exact="influenza" post="infection are associated with the risk of death, especially"/>
  <result pre="elderly, and in immunocompromised patients [18]. Therefore, efficient control of" exact="influenza" post="outbreaks requires the discovery and development of novel antiviral"/>
  <result pre="between virus and host cell proteins are strong determinants of" exact="influenza" post="A virus pathogenicity [29,30]. Once influenza virus gains access"/>
  <result pre="are strong determinants of influenza A virus pathogenicity [29,30]. Once" exact="influenza" post="virus gains access to the human respiratory tract, it"/>
  <result pre="of virus-infected mice and are important for the pathogenesis of" exact="influenza" post="virus infection [33]. The effect of influenza virus on"/>
  <result pre="the pathogenesis of influenza virus infection [33]. The effect of" exact="influenza" post="virus on the pro-/antioxidant balance in the host cells"/>
  <result pre="direct role for ROS-induced tissue damage in the pathogenesis of" exact="influenza" post="virus infection in the lungs of infected mice [35]."/>
  <result pre="reactive peroxynitrite, may be the most important pathogenic factors in" exact="influenza" post="virus-induced pneumonia in mice [36]. High influenza viral load"/>
  <result pre="may be the most important pathogenic factors in influenza virus-induced" exact="pneumonia" post="in mice [36]. High influenza viral load activates a"/>
  <result pre="pathogenic factors in influenza virus-induced pneumonia in mice [36]. High" exact="influenza" post="viral load activates a burst in phagocytic cells. The"/>
  <result pre="these cells [37]. Furthermore, it has been suggested that the" exact="influenza" post="virus activates phagocytes by the generation of metabolites derived"/>
  <result pre="to promote infection. Murphy et al., 1998, showed that experimental" exact="influenza" post="virus infection increased oral NO, but not nasal exhaled"/>
  <result pre="directly contribute to the respiratory tract symptoms after infection with" exact="influenza" post="A virus [38]. With regards to surface glycoproteins, neuraminidase"/>
  <result pre="active site in both type A and type B of" exact="influenza" post="viruses and is the target of neuraminidase inhibitors. Resistance"/>
  <result pre="accompanied by mutations in hemagglutinin, could affect the antigenicity of" exact="influenza" post="viruses [39]. Influenza infection has been shown to increase"/>
  <result pre="cytokine balance and an increase in pro-inflammatory cytokines production. After" exact="influenza" post="infection, IFN-Î±/Î², IFN-Î±, and IL-2 appear to have protective"/>
  <result pre="IFN-Î±/Î², IFN-Î±, and IL-2 appear to have protective roles against" exact="influenza" post="infection, while IL-1, TNF-Î±, and IL-6 seem to be"/>
  <result pre="synthesis and limits viral spread [42]. Human MxA protein inhibits" exact="influenza" post="viral replication at post-transcriptional and translational levels [43]. IFNÎ±/Î²"/>
  <result pre="a dual role (beneficial and harmful to the patient) during" exact="influenza" post="infection. It is produced by several immune cells, including"/>
  <result pre="study by Jacoby et al., 2002, it was discussed that" exact="influenza" post="virus infection may cause an increase in airway inflammation"/>
  <result pre="cause an increase in airway inflammation and bronchoconstriction, particularly during" exact="asthma" post="attacks. Inflammatory mediators, which are produced by epithelial cells"/>
  <result pre="are produced by epithelial cells and increase in response to" exact="influenza" post="virus infection, include IL-6 and IL-8, regulated on activation,"/>
  <result pre="cell growth [53]. Palamara et al., 2005, also showed that" exact="influenza" post="A virus infection causes the activation of various MAPK"/>
  <result pre="or deactivate protein functionality [58]. It has been reported that" exact="influenza" post="virus is propagated in the epithelial cells lining the"/>
  <result pre="plays a crucial role in the host defense mechanism against" exact="influenza" post="virus infection, especially in its early stage, as the"/>
  <result pre="was investigated on liver monooxygenase activity and lipid peroxidation in" exact="influenza" post="virus-infected mice. These models, in combination with influenza virus"/>
  <result pre="peroxidation in influenza virus-infected mice. These models, in combination with" exact="influenza" post="virus infection, were associated with graduated oxidative disturbances in"/>
  <result pre="reductase, and liver monooxygenases [60]. At a later stage, following" exact="influenza" post="A virus (A/Aichi/2/68/H3N2) infection, several disorganizations were recorded in"/>
  <result pre="and development of hypoxia, increase in PaCO2 and development of" exact="metabolic acidosis," post="eicosanoids and prostaglandin E2 and enhanced immune response, oxidative"/>
  <result pre="generation of free radicals mostly in the early stage of" exact="influenza" post="virus infection in blood and lung. The promising effect"/>
  <result pre="to the induction of inducible nitric oxide synthase (iNOS) during" exact="influenza" post="virus infection. ROS, reactive nitrogen species (RNS), and secondary"/>
  <result pre="[62]. ROS production is an important host defense mechanism against" exact="influenza" post="virus infection. However, excessive superoxide production may stimulate the"/>
  <result pre="ROS in mammalian inflammatory cells, NADPH oxidase 2 (Nox2), reduces" exact="influenza" post="A virus-induced lung injury and virus replication [63]. Superoxide"/>
  <result pre="with antiviral drugs could synergistically reduce the lethal effects of" exact="influenza" post="virus infections [64]. 1.3. Medicinal Plants Medicinal plants have"/>
  <result pre="numerous diseases, including life-threatening diseases such as viral diseases and" exact="cancer" post="[74]. 1.4. Quercetin and Its Derivatives Quercetin (3,3â€²,4â€²,5,7-pentahydroxyflavone) is"/>
  <result pre="mode of attack of quercetin and its derivatives on the" exact="influenza" post="virus life cycle in different parts of the cell."/>
  <result pre="described the therapeutic effect of quercetin and derivatives acting against" exact="influenza" post="virus. Choi et al., 2009, showed that quercetin 3-rhamnoside"/>
  <result pre="3-rhamnoside (Q3R) isolated from Houttuynia cordata has antiviral activity against" exact="influenza" post="A/WS/33 virus in vitro [86]. According to ethnopharmacological studies,"/>
  <result pre="used medicinal plant in China, was characterized against the recombinant" exact="influenza" post="virus PR8-NS1-Gluc in MDCK cells with Gaussia luciferase viral"/>
  <result pre="epigallocatechin gallate (EGCG) were tested for their antiviral activity against" exact="influenza" post="A and B H1N1 viruses (A/swine/OH/511445/2007 (H1N1) and human"/>
  <result pre="(A/swine/OH/511445/2007 (H1N1) and human A/PR/8/34 (H1N1), as well as human" exact="influenza" post="B virus (B/Lee/40). The Hypericum perforatum and Equisetum arvense"/>
  <result pre="with previously described findings, isoquercetin inhibited the replication of both" exact="influenza" post="A and B viruses at the lowest 50% effective"/>
  <result pre="the in vitro antiviral activity of tea polyphenol compounds against" exact="influenza" post="A/PR/8/34 and B/Lee/1940 viruses. Tea polyphenols mainly contain catechins,"/>
  <result pre="CC50, showed IC50 value of more than 42.28 in both" exact="influenza" post="A and B virus treatments. This study did not"/>
  <result pre="but, quercetin, which was tested in different periods, also caused" exact="suppression" post="of influenza virus-induced cell death. They evaluated the effects"/>
  <result pre="which was tested in different periods, also caused suppression of" exact="influenza" post="virus-induced cell death. They evaluated the effects of isorhamnetin"/>
  <result pre="in Vaccinium oldhamii, belonging to the blueberry family, which inhibit" exact="influenza" post="infection. Three fractions of 30%, 40%, and 50% ethanol"/>
  <result pre="quercetin-3-O-rhamnoside, and quercetin-O-pentoside-O-rhamnoside compounds were identified. The inhibitory activity against" exact="influenza" post="virus (A/Yamagata/165/2009/H1N1/pdm09) was calculated by a reduction in the"/>
  <result pre="in this study that this activity was due to the" exact="suppression" post="of influenza replication inside the cells and not due"/>
  <result pre="study that this activity was due to the suppression of" exact="influenza" post="replication inside the cells and not due to the"/>
  <result pre="was structurally related to EGCG, showed favorable antiviral activity against" exact="influenza" post="virus in MDCK cell culture comparable to that of"/>
  <result pre="investigate the antiviral activity of polyphenol-rich extracts containing quercetin against" exact="influenza" post="A/PR/8/34 and B/Lee/1940 viruses. Two mechanisms were assumed for"/>
  <result pre="were assumed for the antiviral activity of compounds on both" exact="influenza" post="A and B viruses, i.e., one is at the"/>
  <result pre="a ketone at the C-4 position is essential for inhibiting" exact="influenza" post="virus as NA inhibitor. However, the presence of more"/>
  <result pre="seems that dimeric compounds are more potent antivirals against both" exact="influenza" post="A and B viruses than the monomers such as"/>
  <result pre="96â€&quot;98% purity by HPLC) exhibited moderate inhibitory activity against pandemic" exact="influenza" post="virus A/H1N1/pdm09 in MDCK cells (EC50 6.0 Âµg/mL, CC50"/>
  <result pre="pain) was subjected to in vitro bioassay-guided fractionation using human" exact="influenza" post="virus A/Panama/1/68 (H3N2). Several compounds were isolated, including 3-O-methylquercetin"/>
  <result pre="value could be obtained. These compounds showed no activity against" exact="influenza" post="virus as evaluated by direct immunofluorescence [102]. Rumex pictus"/>
  <result pre="of antiviral activity, they were found to be inactive against" exact="influenza" post="A virus infection in this study [104]. The anti-influenza"/>
  <result pre="or in combination with rimantadine, was investigated with respect to" exact="influenza" post="A (H3N2) infection in cultures of chorioallantoic membranes of"/>
  <result pre="Its dried fruit is widely used for the treatment of" exact="rheumatoid arthritis," post="prosopalgia, and hepatitis, as well as being used as"/>
  <result pre="used for medicinal purposes, was evaluated against different viruses, including" exact="influenza" post="A virus (PR/8/34), in RAW264.7 and HEK293T cells). The"/>
  <result pre="viruses [111]. The inhibitory effect of Epimedium koreanum Nakai toward" exact="influenza" post="A/PR/8/34 was shown by reduction in cell death and"/>
  <result pre="and antiviral activity of aqueous extract of Eupatorium fortunei against" exact="influenza" post="A virus, Newcastle disease virus, and vesicular stomatitis virus"/>
  <result pre="fortunei against influenza A virus, Newcastle disease virus, and vesicular" exact="stomatitis" post="virus in murine RAW264.7 macrophage cells [112]. Fifteen active"/>
  <result pre="a source of quercetin-3-O-Î±-L-rhamnopyranoside and for its immunomodulatory properties against" exact="influenza" post="A virus. This plant has traditionally been used to"/>
  <result pre="quercetin and its derivatives to counteract signaling pathways used for" exact="influenza" post="virus propagation. Quercetin and oseltamivir were evaluated for their"/>
  <result pre="protein level in A549 human lung epithelial cells infected by" exact="influenza" post="A H1N1 (A1/Qian fang/166/85) in parallel with ribavirin. The"/>
  <result pre="is a key host cell response to viral infections, including" exact="influenza" post="virus infection [115]. However, it has been shown that"/>
  <result pre="influenza virus infection [115]. However, it has been shown that" exact="influenza" post="A virus is able to inhibit autophagy [119], which"/>
  <result pre="synthesis [121]. It has been suggested as a target for" exact="influenza" post="drugs, as it is highly structurally conserved across different"/>
  <result pre="influenza drugs, as it is highly structurally conserved across different" exact="influenza" post="virus types and strains [122]. The Dianthus superbus is"/>
  <result pre="production, and autophagy induction. MDCK cell line was infected with" exact="influenza" post="viruses A and B (A/Vic/3/75 (H3N2), A/PR/8/34 (H1N1), B/Maryland/1/59,"/>
  <result pre="The authors investigated the effect of periodic quercetin treatments against" exact="influenza" post="A virus H1N1 (low pathogenic human IAV H1N1 strain"/>
  <result pre="expression modulation. Significantly higher cell viability, lower expression of the" exact="influenza" post="PA gene, reduced apoptosis, and reduced cell death were"/>
  <result pre="examined in response to simultaneous combination treatment with quercetin-3-O-Î±-L-rhamnopyranoside and" exact="influenza" post="A/PR/8/34 by detecting RhoA GTPase protein and caspase-3 activity."/>
  <result pre="of Aloe arborescens significantly reduced the proliferation of IAV and" exact="influenza" post="B virus (IBV) in vitro [127]. The antiviral activity"/>
  <result pre="that this extract inhibited autophagy, which was otherwise induced by" exact="influenza" post="A virus in MDCK cells, while treatment with individual"/>
  <result pre="from Dianthus superbus L and verified by spectroscopic analysis, against" exact="influenza" post="A and B virus infection. This plant is a"/>
  <result pre="A/PR/8/34, A/Victoria/3/75, A/WS/33, B/Maryland/1/59, and B/Lee/40, respectively. Quercetin 3-glucoside blocked" exact="influenza" post="A/PR/8/34 replication in a time-dependent assay (âˆ’2 and âˆ’1"/>
  <result pre="been evaluated on neuraminidase activity (NA) of different types of" exact="influenza" post="virus. In a study by Rakers et al., 2014,"/>
  <result pre="extract of the leaves of Zanthoxylum piperitum was investigated against" exact="influenza" post="A/NWS/33 (H1N1) virus in vitro. Several properties such as"/>
  <result pre="oseltamivir, they have the capacity as antiviral agents against the" exact="influenza" post="A virus [132]. Six flavonoids (quercetin-3-sophoroside, kaempferol-3-sophoroside, kaempferol-3-sambubioside, kaempferol-3-neohesperidoside,"/>
  <result pre="world for its medical capacities against flu, ulcers, colds, and" exact="anemia" post="[134]. It is rich in vitamins, lipids, carbohydrates, proteins,"/>
  <result pre="LC-MS/MS. The butanol extract showed potent antiviral activity against both" exact="influenza" post="A and B viruses (A/PR/8/34 and B/LEE/40) with IC50"/>
  <result pre="from traditional Chinese medicine, were tested in molecular docking against" exact="influenza" post="A virus H1N1 (A/PR/8/34). They showed strong binding abilities"/>
  <result pre="one of the common Chinese herbal formulas used to treat" exact="influenza" post="and cold symptoms. It consists of Radix isatidis, Folium"/>
  <result pre="rupestris. The effectiveness of this formula has been shown against" exact="influenza" post="A (H1N1, H3N2, oseltamivir resistant H1N1, and amantadine-resistant H3N2)"/>
  <result pre="hispidulin were selected to evaluate their potential inhibitory effect on" exact="influenza" post="H1N1 virus by looking for their binding energy to"/>
  <result pre="amantadine (âˆ’4.52 kcal/mol). Thus, the inhibition of autophagy induced by" exact="influenza" post="virus infection may explain the antiviral activity of Aloe"/>
  <result pre="[125]. Another molecular docking study revealed higher binding activities towards" exact="influenza" post="polymerase and surface glycoproteins for flavonol glycosides [135]. Molecular"/>
  <result pre="multitarget predictive tool for the discovery of new drugs against" exact="influenza" post="[140]. 2.1.7. Hemagglutinin Inhibitory Activity Quercetin has been reported"/>
  <result pre="2.1.7. Hemagglutinin Inhibitory Activity Quercetin has been reported to counteract" exact="influenza" post="infection in the early stages by interacting with the"/>
  <result pre="the early stages by interacting with the HA2 subunit of" exact="influenza" post="HA protein and inhibited virus-cell fusion. Quercetin exhibited an"/>
  <result pre="(MST) assay was conducted, which showed that quercetin interacted with" exact="influenza" post="HA protein in a dose-dependent manner. Using the pseudovirus-based"/>
  <result pre="confirmed the specific interference with the function of the H5N1" exact="influenza" post="HA envelope protein [141]. 2.2. In Vivo and Human"/>
  <result pre="rutin and quercetin, on the experimental infection of mice with" exact="influenza" post="virus A/PR8/34 (H1N1). When the extract was administered, 3"/>
  <result pre="observed [142]. The protective effect of quercetin was investigated during" exact="influenza" post="virus-induced oxidative stress in adult male Swiss albino mice"/>
  <result pre="oxidative stress in adult male Swiss albino mice infected with" exact="influenza" post="virus (A/Hong Kong/8/68). The mice were infected intranasally with"/>
  <result pre="quercetin was effective in ameliorating the oxidative stress induced during" exact="influenza" post="virus infection [143]. In addition, quercetin reduced the oxidative"/>
  <result pre="[143]. In addition, quercetin reduced the oxidative stress induced by" exact="influenza" post="virus A/Udorn/317/72 (H3N2) infection in mice. Alveolar macrophages were"/>
  <result pre="observed in LPO levels after quercetin administration compared to untreated" exact="influenza" post="infection [144]. Quercetin protects the lungs by maintaining the"/>
  <result pre="and quercetin on oxidative stress in healthy and the experimental" exact="influenza" post="virus (A/Aichi/2/68 (H3N2))-infected mice. These flavonoids were injected intraperitoneally"/>
  <result pre="of each compound to counteract the pathogenic processes of H5N1" exact="influenza" post="in humans [149]. It has been shown previously that"/>
  <result pre="inoculated intranasally with a standardized dose (0.04 hemagglutinating units) of" exact="influenza" post="virus A/PR/8/34 (H1N1) and monitored daily for 21 days."/>
  <result pre="of isoquercetin to 4-week-old female BALB/c mice infected with human" exact="influenza" post="A virus showed a significant decrease in virus titers"/>
  <result pre="L., a well-known traditional Chinese medicinal plant, was investigated on" exact="influenza" post="A virus in infected mice. A practical, specific, sensitive,"/>
  <result pre="The compound was able to suppress lung edema induced by" exact="influenza" post="A virus. In 3 and 6 mg/kg concentrations, it"/>
  <result pre="al., 2012 evaluated the effect of quercetin 3-rhamnoside (Q3R) on" exact="influenza" post="A/WS/33 virus-infected mice. The mice were orally treated with"/>
  <result pre="per dose) at 2 h before and once daily after" exact="influenza" post="virus infection for 6 days. They exhibited a significant"/>
  <result pre="an attractive lead for the development of antiviral agents against" exact="influenza" post="virus [155]. The protective effect of Epimedium koreanum Nakai"/>
  <result pre="Nakai against lethal doses of different types of highly pathogenic" exact="influenza" post="A viruses (H1N1, H5N2, H7N3, and H9N2) was determined"/>
  <result pre="similar protection levels, which were around 80% for all the" exact="influenza" post="A subtypes tested. Altogether, these results showed that the"/>
  <result pre="survival of mice against lethal infections of different subtypes of" exact="influenza" post="A viruses. They suggested that oral administration of this"/>
  <result pre="effect of the compounds. BALB/c female mice were infected with" exact="influenza" post="A H1N1 (A/PR/8/34), and then treated with the compounds"/>
  <result pre="and in vivo evaluation of quercetin and its derivatives against" exact="influenza" post="infection, which may highlight experimental parameters and bioavailability issues"/>
  <result pre="the importance and efficacy of quercetin and other flavonols against" exact="influenza" post="virus infection, flavonoids have attracted increasing attention as a"/>
  <result pre="antiviral compound on the basis of its antiviral activity against" exact="influenza" post="A virus and SARS-CoV-2 infections and is a noteworthy"/>
  <result pre="manuscript. D.S., D.H., and J.M. participated in the section focusing" exact="influenza" post="virus description. Authorship must be limited to those who"/>
  <result pre="HSF human skin fibroblasts iNOS inducible nitric oxide synthase IV" exact="influenza" post="virus IAV influenza A virus IC50 inhibitory concentration 50%"/>
  <result pre="fibroblasts iNOS inducible nitric oxide synthase IV influenza virus IAV" exact="influenza" post="A virus IC50 inhibitory concentration 50% IFN interferon IL"/>
  <result pre="Plant Extracts with Novel Anti-Influenza ActivityPLoS ONE20138e7929310.1371/journal.pone.007929324312177 2.BouvierN.M.PaleseP.The biology of" exact="influenza" post="virusesVaccine200826D49D5310.1016/j.vaccine.2008.07.03919230160 3.PaleseP.ShawM.Orthomyxoviridae: The Viruses and their ReplicationFields Virol.20072616471689 4.collab:"/>
  <result pre="influenza-associated respiratory mortality: A modelling studyLancet20183911285130010.1016/S0140-6736(17)33293-229248255 6.MaciasA.E.McElhaneyJ.ChavesS.S.NealonJ.NunesM.C.SamsonS.I.SeetB.T.WeinkeT.YuH.The disease burden of" exact="influenza" post="beyond respiratory illnessVaccine202026410.1016/j.vaccine.2020.09.048 7.MehrbodP.AndeS.R.AlizadehJ.RahimizadehS.ShariatiA.MalekH.HashemiM.GloverK.K.M.SherA.A.CoombsK.M.et al.The roles of apoptosis, autophagy"/>
  <result pre="roles of apoptosis, autophagy and unfolded protein response in arbovirus," exact="influenza" post="virus, and HIV infectionsVirulence20191037641310.1080/21505594.2019.160580330966844 8.PutriW.C.MuscatelloD.J.StockwellM.S.NewallA.Economic burden of seasonal influenza"/>
  <result pre="arbovirus, influenza virus, and HIV infectionsVirulence20191037641310.1080/21505594.2019.160580330966844 8.PutriW.C.MuscatelloD.J.StockwellM.S.NewallA.Economic burden of seasonal" exact="influenza" post="in the United StatesVaccine2018363960396610.1016/j.vaccine.2018.05.05729801998 9.KhorramdelazadH.KazemiM.H.NajafiA.KeykhaeeM.EmamehR.Z.FalakR.Immunopathological similarities between COVID-19 and"/>
  <result pre="Investigating the consequences of Co-infectionMicrob. Pathog.202010455410.1016/j.micpath.2020.10455433157216 10.DingQ.LuP.FanY.XiaY.LiuM.The clinical characteristics of" exact="pneumonia" post="patients coinfected with 2019 novel coronavirus and influenza virus"/>
  <result pre="characteristics of pneumonia patients coinfected with 2019 novel coronavirus and" exact="influenza" post="virus in Wuhan, ChinaJ. Med. Virol.2020921549155510.1002/jmv.2578132196707 11.GeW.JingdongM.JialunG.YangS.YueW.DanF.MuruW.De-anT.PeiyuanL.Is Co-Infection with"/>
  <result pre="a Protective Factor of COVID-19?Lancet Infect. Dis.202010.2139/ssrn.3576904 12.ZhangA.J.ChanJ.F.LiuF.LiC.ChenY.ChuH.LauS.Y.WangP.ChanC.C.PoonV.K.et al.Co-infection by" exact="severe acute respiratory syndrome" post="coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity"/>
  <result pre="12.ZhangA.J.ChanJ.F.LiuF.LiC.ChenY.ChuH.LauS.Y.WangP.ChanC.C.PoonV.K.et al.Co-infection by severe acute respiratory syndrome coronavirus 2 and" exact="influenza" post="A(H1N1)pdm09 virus enhances the severity of pneumonia in golden"/>
  <result pre="coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of" exact="pneumonia" post="in golden Syrian hamstersClin. Infect. Dis.2020ciaa174710.1093/cid/ciaa174733216851 13.DrakeT.HoA.TurtleL.RussellC.HarrisonE.SempleC.Influenza Infection in"/>
  <result pre="14.HaydenF.G.Respiratory viral threatsCurr. Opin. Infect. Dis.20061916917810.1097/01.qco.0000216628.51563.b116514342 15.SoemaP.C.KompierR.AmorijJ.-P.KerstenG.F.Current and next generation" exact="influenza" post="vaccines: Formulation and production strategiesEur. J. Pharm. Biopharm.20159425126310.1016/j.ejpb.2015.05.02326047796 16.BarikS.New"/>
  <result pre="influenzaBMC Med.20121010410.1186/1741-7015-10-10422973873 17.MeijerA.Rebelo-De-AndradeH.CorreiaV.BesselaarT.Drager-DayalR.FryA.GregoryV.GubarevaL.V.KageyamaT.LackenbyA.et al.Global update on the susceptibility of human" exact="influenza" post="viruses to neuraminidase inhibitors, 2012â€&quot;2013Antivir. Res.2014110314110.1016/j.antiviral.2014.07.00125043638 18.collab: WHOGlobal Influenza"/>
  <result pre="2019WHOGeneva, Switzerland2019Available online: https://apps.who.int/iris/handle/10665/311184(accessed on 20 June 2020) 19.FedsonD.S.Confronting an" exact="influenza" post="pandemic with inexpensive generic agents: Can it be done?Lancet"/>
  <result pre="changes in hemagglutinin contribute to the replication of Ooeltamivir-resistant H1N1" exact="influenza" post="virusesJ. Virol.20128612112710.1128/JVI.06085-1122013054 27.HussainM.GalvinH.D.HawT.Y.NutsfordA.N.HusainM.Drug resistance in influenza A virus: The"/>
  <result pre="replication of Ooeltamivir-resistant H1N1 influenza virusesJ. Virol.20128612112710.1128/JVI.06085-1122013054 27.HussainM.GalvinH.D.HawT.Y.NutsfordA.N.HusainM.Drug resistance in" exact="influenza" post="A virus: The epidemiology and managementInfect. Drug Resist.20171012113410.2147/IDR.S10547328458567 28.LampejoT.Influenza"/>
  <result pre="resistance: An overviewEur. J. Clin. Microbiol. Infect. Dis.2020391201120810.1007/s10096-020-03840-932056049 29.YeganehB.GhavamiS.KroekerA.L.MahoodT.H.StelmackG.L.KlonischT.CoombsK.M.HalaykoA.J.Suppression of" exact="influenza" post="A virus replication in human lung epithelial cells by"/>
  <result pre="concentrations bafilomycin A1Am. J. Physiol. Cell. Mol. Physiol.2015308L270L28610.1152/ajplung.00011.2014 30.YeganehB.MoghadamA.R.TranA.T.RahimM.N.AndeS.R.HashemiM.CoombsK.M.GhavamiS.Asthma and" exact="influenza" post="virus infection:focusing on cell death and stress pathways in"/>
  <result pre="influenza virus infection:focusing on cell death and stress pathways in" exact="influenza" post="virus replicationIran. J. Allergy Asthma Immunol.20131211723454774 31.WangJ.Pathogenesis of InfluenzaRadiology"/>
  <result pre="of Influenza: A Practical ApproachSpringerDordrecht, The Netherlands20169 32.FukuyamaS.KawaokaY.The pathogenesis of" exact="influenza" post="virus infections: The contributions of virus and host factorsCurr."/>
  <result pre="during viral infection: A reviewFree. Radic. Biol. Med.19962164164910.1016/0891-5849(96)00131-18891667 36.AkaikeT.NoguchiY.IjiriS.SetoguchiK.SugaM.ZhengY.M.DietzscholdB.MaedaH.Pathogenesis of" exact="influenza" post="virus-induced pneumonia: Involvement of both nitric oxide and oxygen"/>
  <result pre="43.PavlovicJ.HallerO.StaeheliP.Human and mouse Mx proteins inhibit different steps of the" exact="influenza" post="virus multiplication cycleJ. Virol.1992662564256910.1128/JVI.66.4.2564-2569.19921548781 44.ToughD.F.BorrowP.SprentJ.Induction of Bystander T Cell"/>
  <result pre="advances in anti-influenza therapyCurr. Med. Chem.2010172101214010.2174/09298671079129995720423307 59.LiuB.MoriI.HossainJ.DongL.ChenZ.KimuraY.Local immune responses to" exact="influenza" post="virus infection in mice with a targeted disruption of"/>
  <result pre="cold-restraint stress on liver monooxygenase activity and lipid peroxidation of" exact="influenza" post="virus-infected miceArch. Toxicol.2002769610310.1007/s00204-001-0306-611914779 61.MilevaM.BakalovaR.TanchevaL.GalabovA.RibarovS.Effect of vitamin E supplementation on"/>
  <result pre="E supplementation on lipid peroxidation in blood and lung of" exact="influenza" post="virus infected miceComp. Immunol. Microbiol. Infect. Dis.20022511110.1016/S0147-9571(01)00010-811831742 62.Valyi-NagyT.DermodyT.S.Role of"/>
  <result pre="systemHistol. Histopathol.20052095796715944946 63.VlahosR.StambasJ.SelemidisS.Suppressing production of reactive oxygen species (ROS) for" exact="influenza" post="A virus therapyTrends Pharmacol. Sci.2012333810.1016/j.tips.2011.09.00121962460 64.MilevaM.Oxidative stress as a"/>
  <result pre="Pharmacol. Sci.2012333810.1016/j.tips.2011.09.00121962460 64.MilevaM.Oxidative stress as a target for medication of" exact="influenza" post="virus infectionActa Microbiol. Bulg.20163239 65.KhalafallaM.M.Active principle from moringa oleifera"/>
  <result pre="AdultsJ. Nutr.200813875376010.1093/jn/138.4.75318356331 78.MehrbodP.AbdallaM.A.FotouhiF.HeidarzadehM.AroA.O.EloffJ.N.McGawL.J.FasinaF.O.Immunomodulatory properties of quercetin-3-O-Î±-L-rhamnopyranoside from Rapanea melanophloeos against" exact="influenza" post="a virusBMC Complement. Altern. Med.20181818410.1186/s12906-018-2246-129903008 79.LinC.-F.LeuY.-L.Al-SuwayehS.A.KuM.-C.HwangT.-L.FangJ.-Y.Anti-inflammatory activity and percutaneous"/>
  <result pre="and catechin metabolitesFood Funct.2014579710.1039/c3fo60441a24573487 81.GansukhE.KazibweZ.PanduranganM.JudyG.KimD.H.Probing the impact of quercetin-7-O-glucoside on" exact="influenza" post="virus replication influencePhytomedicine20162395896710.1016/j.phymed.2016.06.00127387404 82.LiM.Y.XuZ.Quercetin in a lotus leaves extract"/>
  <result pre="Res.20083164064410.1007/s12272-001-1206-5 83.AtashpourS.FouladdelS.MovahhedT.K.BarzegarE.GhahremaniM.H.OstadS.N.AziziE.Quercetin induces cell cycle arrest and apoptosis in CD133+" exact="cancer" post="stem cells of human colorectal HT29 cancer cell line"/>
  <result pre="apoptosis in CD133+ cancer stem cells of human colorectal HT29" exact="cancer" post="cell line and enhances anticancer effects of doxorubicinIran J."/>
  <result pre="in gerbilsFood Chem. Toxicol.201352536010.1016/j.fct.2012.10.03023123425 86.ChoiH.J.SongJ.H.ParkK.S.KwonD.-H.Inhibitory effects of quercetin 3-rhamnoside on" exact="influenza" post="A virus replicationEur. J. Pharm. Sci.20093732933310.1016/j.ejps.2009.03.00219491023 87.MehrbodP.EbrahimiS.N.FotouhiF.EskandariF.EloffJ.N.McGawL.FasinaF.O.Experimental validation and"/>
  <result pre="for Anti-Influenza Virus ComponentsEvid. Based Complement. Altern. Med.20192019941492610.1155/2019/9414926 95.KimY.NarayananS.ChangK.-O.Inhibition of" exact="influenza" post="virus replication by plant-derived isoquercetinAntivir. Res.20108822723510.1016/j.antiviral.2010.08.01620826184 96.IbrahimA.K.YoussefA.I.ArafaA.S.AhmedS.Anti-H5N1 virus flavonoids"/>
  <result pre="97.YangZ.BaiL.HuangW.-B.LiX.-Z.ZhaoS.-S.ZhongN.JiangZ.Comparison of in vitro antiviral activity of tea polyphenols against" exact="influenza" post="A and B viruses and structureâ€&quot;activity relationship analysisFitoterapia201493475310.1016/j.fitote.2013.12.01124370660 98.SekizawaH.IkutaK.Ohnishi-KameyamaM.NishiyamaK.SuzutaniT.Identification"/>
  <result pre="substituted quercetinsBioorg. Med. Chem. Lett.20122235335610.1016/j.bmcl.2011.10.11922115591 100.LiuA.WangH.-D.LeeS.M.-Y.WangY.-T.DuG.Structureâ€&quot;activity relationship of flavonoids as" exact="influenza" post="virus neuraminidase inhibitors and their in vitro anti-viral activitiesBioorg."/>
  <result pre="of some antioxidants/antihypoxants and their combinations with remantadine against human" exact="influenza" post="A(H3N2) virus studied in in vitro modelsExp. Clin. Farmacol.2007703337"/>
  <result pre="VirusesFront. Pharmacol.2017851110.3389/fphar.2017.0051128824435 113.MehrbodP.AbdallaM.A.NjoyaE.M.AhmedA.S.FotouhiF.FarahmandB.GadoD.A.TabatabaianM.FasanmiO.G.EloffJ.N.et al.South African medicinal plant extracts active against" exact="influenza" post="A virusBMC Complement. Altern. Med.20181811210.1186/s12906-018-2184-y29587734 114.DonelanN.R.BaslerC.F.Garcia-SarstreA.A Recombinant Influenza A"/>
  <result pre="and Is Attenuated inMiceJ. Virol.200377132571326610.1128/JVI.77.24.13257-13266.200314645582 115.YeganehB.GhavamiS.RahimN.KlonischT.HalaykoA.CoombsK.M.Autophagy activation is required for" exact="influenza" post="A virus-induced apoptosis and replicationBiochim. Biophys. Acta Mol. Cell"/>
  <result pre="and the Influenza Virus M2 ProteinCell Host Microbe2009629930010.1016/j.chom.2009.09.00919837369 121.DasK.AraminiJ.M.MaL.-C.KrugR.M.ArnoldE.Structures of" exact="influenza" post="A proteins and insights into antiviral drug targetsNat. Struct."/>
  <result pre="of the upper respiratory tractPhytomedicine20152291192010.1016/j.phymed.2015.06.00626321740 128.LiS.-W.YangT.-C.LaiC.-C.HuangS.-H.LiaoJ.-M.WanL.LinY.-J.LinC.-W.Antiviral activity of aloe-emodin against" exact="influenza" post="A virus via galectin-3 up-regulationEur. J. Pharmacol.201473812513210.1016/j.ejphar.2014.05.02824877694 129.LÃ³pez-ExpÃ³sitoI.CastilloA.YangN.LiangB.LiX.-M.Chinese herbal"/>
  <result pre="the effect of quercetin 3-glucoside from Dianthus superbus L against" exact="influenza" post="virus infection- in vitro and in silico biochemical and"/>
  <result pre="toxicological screeningFood Chem. Toxicol.202013511098510.1016/j.fct.2019.11098531765700 131.RakersC.SchwerdtfegerS.-M.MortierJ.DuweS.WolffT.WolberG.MelzigM.F.Inhibitory potency of flavonoid derivatives on" exact="influenza" post="virus neuraminidaseBioorg. Med. Chem. Lett.2014244312431710.1016/j.bmcl.2014.07.01025096296 132.DuanJ.LouJ.ZhangQ.KeJ.QiY.ShenN.ZhuB.ZhongR.WangZ.LiuL.et al.A Genetic Variant"/>
  <result pre="Rep.201661909510.1038/srep1909526754609 138.YinJ.MaL.WangH.YanH.HuiqiangW.JiangW.LiY.Chinese herbal medicine compound Yi-Zhi-Hao pellet inhibits replication of" exact="influenza" post="virus infection through activation of heme oxygenase-1Acta Pharm. Sin."/>
  <result pre="B2017763063710.1016/j.apsb.2017.05.00629159022 139.SadatiS.M.GheibiN.RanjbarS.HashemzadehM.S.Docking study of flavonoid derivatives as potent inhibitors of" exact="influenza" post="H1N1 virus neuraminidaseBiomed. Rep.201810333810.3892/br.2018.117330588301 140.XuL.JiangW.JiaH.ZhengL.XingJ.LiuA.DuG.Discovery of Multitarget-Directed Ligands Against"/>
  <result pre="extract, of rutin and of a rutin-quercetin mixture on experimental" exact="influenza" post="virus infection in miceVirology1981322132157303493 143.MscT.A.N.R.LakshmiA.N.V.AnandT.RaoL.V.SharmaG.Protective effects of quercetin during"/>
  <result pre="influenza virus infection in miceVirology1981322132157303493 143.MscT.A.N.R.LakshmiA.N.V.AnandT.RaoL.V.SharmaG.Protective effects of quercetin during" exact="influenza" post="virus-induced oxidative stressAsia Pac. J. Clin. Nutr.2000931431710.1046/j.1440-6047.2000.00162.x24394509 144.KumarP.SharmaS.KhannaM.RajH.G.Effect of"/>
  <result pre="on lipid peroxidation and changes in lung morphology in experimental" exact="influenza" post="virus infectionInt. J. Exp. Pathol.20038412713410.1046/j.1365-2613.2003.00344.x12974942 145.KumarP.KhannaM.SrivastavaV.TyagiY.K.RajH.G.RaviK.Effect of quercetin supplementation"/>
  <result pre="Pathol.20038412713410.1046/j.1365-2613.2003.00344.x12974942 145.KumarP.KhannaM.SrivastavaV.TyagiY.K.RajH.G.RaviK.Effect of quercetin supplementation on lung antioxidants after experimental" exact="influenza" post="virus infectionExp. Lung Res.20053144945910.1080/01902149092708816019982 146.SavovV.M.GalabovA.S.TantchevaL.P.MilevaM.M.PavlovaE.StoevaE.S.BraykovaA.A.Effects of rutin and quercetin"/>
  <result pre="146.SavovV.M.GalabovA.S.TantchevaL.P.MilevaM.M.PavlovaE.StoevaE.S.BraykovaA.A.Effects of rutin and quercetin on monooxygenase activities in experimental" exact="influenza" post="virus infectionExp. Toxicol. Pathol.200658596410.1016/j.etp.2006.05.00216793246 147.ChanM.C.W.CheungC.Y.ChuiW.H.TsaoG.S.-W.NichollsJ.M.ChanY.ChanR.W.Y.LongH.T.PoonL.L.M.GuanY.et al.Proinflammatory cytokine responses induced"/>
  <result pre="virus infectionExp. Toxicol. Pathol.200658596410.1016/j.etp.2006.05.00216793246 147.ChanM.C.W.CheungC.Y.ChuiW.H.TsaoG.S.-W.NichollsJ.M.ChanY.ChanR.W.Y.LongH.T.PoonL.L.M.GuanY.et al.Proinflammatory cytokine responses induced by" exact="influenza" post="A (H5N1) viruses in primary human alveolar and bronchial"/>
  <result pre="Avian Influenza Virus H5N1J. Virol.200579101471015410.1128/JVI.79.16.10147-10154.200516051807 149.FrielH.LedermanH.A nutritional supplement formula for" exact="influenza" post="A (H5N1) infection in humansMed. Hypotheses20066757858710.1016/j.mehy.2006.02.04016624496 150.BrownA.S.DavisJ.M.MurphyE.A.CarmichaelM.D.GhaffarA.MayerE.P.Gender Differences in"/>
  <result pre="susceptibility to respiratory infectionJ. Appl. Physiol.1997831461146610.1152/jappl.1997.83.5.14619375306 153.DavisJ.M.MurphyE.A.McClellanJ.L.CarmichaelM.D.GangemiJ.D.Quercetin reduces susceptibility to" exact="influenza" post="infection following stressful exerciseAm. J. Physiol. Integr. Comp. Physiol.2008295R505R50910.1152/ajpregu.90319.2008"/>
  <result pre="protein-angiotensin converting enzyme-2 (ACE2) interactionBiochem. Pharmacol.202017811412310.1016/j.bcp.2020.11412332593613 Figure 1 Structure of" exact="influenza" post="virus. Figure 2 Schematic of the influenza virus life"/>
  <result pre="1 Structure of influenza virus. Figure 2 Schematic of the" exact="influenza" post="virus life cycle and the pathways affected by quercetin"/>
  <result pre="administered orally. In adult male Swiss albino mice infected with" exact="influenza" post="virus (A/Hong Kong/8/68) Decreased oxidative stress by decreasing lipid"/>
  <result pre="and catalase [143] Quercetin In mice infected with A/Udorn/317/72 (H3N2)" exact="influenza" post="virus Decreased lipid peroxidation, protected lungs by maintaining the"/>
  <result pre="of selenium, vitamin E, N-acetyl-cysteine/glutathione, resveratrol and quercetin Against H5N1" exact="influenza" post="in humans Antagonized the pathogenic processes of H5N1 influenza"/>
  <result pre="H5N1 influenza in humans Antagonized the pathogenic processes of H5N1" exact="influenza" post="in humans [149] Short-term quercetin feeding before viral challenge"/>
  <result pre="[153] Isoquercetin In 4-week-old female BALB/c mice infected with human" exact="influenza" post="A virus Decreased IFN-Î³, RANTES, and iNOS as indicators"/>
  <result pre="In 3 and 6 mg/kg concentrations. In mice infected with" exact="influenza" post="virus It could suppress lung edema caused by virus"/>
  <result pre="respectively [154] quercetin 3-rhamnoside (Q3R) In mice infected with A/WS/33" exact="influenza" post="virus Decreased weight loss, necrosis, inflammation, mortality, and lung"/>
  <result pre="mice infected with 5MLD50 of H1N1, H5N2, H7N3, and H9N2" exact="influenza" post="viruses Reduced viral titers and body weight loss. Inhibited"/>
 </snippets>
</snippetsTree>
